Lino Tavares,Bruce E. Reidenberg,Richard S. Sackler,Curtis Wright,Mark A. Alfonso,Benjamin Oshlack,James P. Cassidy,Anthony E. Carpanzano,Rampurna P. Gullapalli,Ihor Shevchuk
申请号:
US14159894
公开号:
US20140199383A1
申请日:
2014.01.21
申请国别(地区):
US
年份:
2014
代理人:
摘要:
The present invention relates to transdermal dosage form (FIGS. 1-3) comprising at least one activating agent and at least one inactivating agent. The dosage form (FIGS. 1-3) releases the inactivating agent upon disruption of the dosage form (FIGS. 1-3) thereby preventing or hindering misuse of the active agent contained in the dosage form (FIGS. 1-3).